We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIS
1676
Nebius Group N.V.
NBIS
$46.7B
$3.1M 0.01%
547,676
SHOP icon
1677
Shopify
SHOP
$200B
$3.08M 0.01%
98,488
-446,022
-82% -$19M
VECO icon
1678
Veeco
VECO
$3.02B
$3.07M 0.01%
+158,458
New +$3.52M
LFACW
1679
CALL
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$3.07M 0.01%
307,457
GE icon
1680
GE Aerospace
GE
$380B
$3.07M 0.01%
77,367
+56,417
+269% +$2.73M
MVLAW
1681
CALL
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$3.05M 0.01%
311,008
-13,881
-4% -$3.17K
FXE icon
1682
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$3.05M 0.01%
31,500
+21,700
+221% +$2.14M
EDNCW
1683
CALL
DELISTED
Endurance Acquisition Corp. Warrant
EDNCW
$3.04M 0.01%
309,109
RTP.WS
1684
CALL
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$3.04M 0.01%
620,000
+45,000
+8% +$221K
FATP
1685
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
$3.04M 0.01%
307,370
LOCC.WS
1686
CALL
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$3.04M 0.01%
316,662
SWAV
1687
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.04M 0.01%
15,887
-13,249
-45% -$2.34M
SUZ icon
1688
Suzano
SUZ
$10B
$3.03M 0.01%
319,337
+53,903
+20% +$567K
ZCAR
1689
DELISTED
Zoomcar
ZCAR
$3.02M 0.01%
150
KMX icon
1690
CarMax
KMX
$8.34B
$3M 0.01%
33,200
-45,282
-58% -$4.26M
CXAC
1691
DELISTED
C5 Acquisition Corporation
CXAC
$3M 0.01%
300,225
+229
+0.1% +$2.28K
BRSL
1692
Brightstar Lottery PLC
BRSL
$2.02B
$2.99M 0.01%
161,170
+90,998
+130% +$1.94M
STRO icon
1693
Sutro Biopharma
STRO
$423M
$2.99M 0.01%
+57,424
New +$3.21M
VCEL icon
1694
Vericel Corp
VCEL
$2.25B
$2.99M 0.01%
118,832
-26,716
-18% -$789K
TRMD icon
1695
TORM
TRMD
$2.99B
$2.98M 0.01%
220,207
+204,402
+1,293% +$2.4M
ITAQ
1696
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
$2.98M 0.01%
299,996
RITM icon
1697
Rithm Capital
RITM
$5.65B
$2.98M 0.01%
+319,775
New +$3.36M
BCSA
1698
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$2.98M 0.01%
299,998
PDCO
1699
DELISTED
Patterson Companies, Inc.
PDCO
$2.97M 0.01%
+97,932
New +$3.07M
TPGY.WS
1700
CALL
DELISTED
TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TPGY.WS
$2.97M 0.01%
299,568
-1,153
-0.4% -$495

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.